Aislinn Antrim, Assistant Editor

Divergent research findings come as investigators seek to understand whether plasma treatments are effective in patients with COVID-19.

State Medicaid programs and other providers will need to learn more about the age distribution of autism among adults enrolled in Medicaid, in order to better serve them.

In addition to increasing physical power, physical training reduced participants’ body fat percentage and increased their oxygen-uptake efficiency.

Eysuvis is the first prescription therapeutic to specifically address short-term needs for patients with dry eye disease, a chronic condition affecting the tears and ocular surface.

The impact of engineering controls, such as ventilation systems, is greater on limiting the spread of COVID-19 than the impact of the most widely applied measures.

Patients with mild or no symptoms of COVID-19 may be infectious for just 10 days.

The study is one of the largest to ever use nutritional biomarkers to investigate bioactive compounds in lowering blood pressure.

The relationship between the flu and heart disease is of particular concern during the pandemic, as severe COVID-19 outcomes have also been associated with exacerbated cardiovascular conditions.

Because restrictions have led to widespread demoralization and frustration, the authors said there has been renewed public interest natural herd immunity approaches.

The right communication system can increase patient engagement and adherence while allowing the pharmacy team to turn their attention to other issues.

The new project follows a collaboration with Walmart announced in August, offering a free comprehensive online training program on opioid stewardship.

Study shows that more than half of older patients hospitalized for heart failure are discharged with 10 or more prescriptions, putting them at significant risk for harm related to high medication burden.

An expert panel discussed the changes to their businesses, due to the COVID-19 pandemic, and what they think the future holds for specialty pharmacy.

Daily mindfulness contributed to less same-day sleepiness, and those with greater mindful attention were 66% less likely to experience symptoms of insomnia.

The trial’s main goal is to compare the health status of participants in the combination treatment group with participants in the remdesivir-only group on day 7.

oNKord is a natural killer cellular immunotherapy product, meaning it can play an important role in controlling and curing both solid and hematological malignancies.

Venetoclax was granted accelerated approval in November 2018, as well as priority review, breakthrough designation, and orphan drug designation.

A recent study shows an unintended increase from 20% to 60% in the proportion of depressed youth without antidepressant treatment.

Although researchers still hope to learn what protection immunoglobulin G antibodies offer against re-infection, this study could have broad implications in the development of a COVID-19 vaccine.

The physical and emotional stress of a COVID-19 diagnosis might be the triggering factor for the development of herpes zoster ophthalmicus.

Evidence-based cancer regimens have been shown to result in better outcomes, including longer survival and less toxicity.

Higher rates of mental health symptoms were found among younger respondents, those who identified themselves as female, and those who reported having a pre-existing mental health condition.

Heart attack, stroke, stent placement, or heart failure hospitalization occurred in 5.3% of the telemonitored group compared with 10.4% of the routine primary care group.

In the absence of a direct head-to-head clinical trial, study may help inform treatment selections for stem cell transplant-ineligible patients.

The authors concluded that a single dose of targeted intraoperative radiotherapy should be an option accessible to health care providers and discussed with patients.

Researchers found that the children of women with preeclampsia had higher systolic blood pressure on average.

Patients treated with remdesivir achieved a median time to recovery of 10 days with remdesivir, compared with 15 days on the placebo.

Although earlier research has shown slight reductions in opioid abuse rates, this analysis is the first to show statistically significant year-to-year declines.

With 35% of Americans saying they do not trust the speed at which clinical trials are progressing, education and transparency are essential to increasing public trust in a COVID-19 vaccine.

Under the $95 million deal, Bartell Drugs’ stores will join 69 existing Rite Aid locations in the Seattle area and will continue to operate under the Bartell Drugs name.